Neural Regeneration Research
FDA Technical Document
It has been evaluated in multiple Phase 3 randomized controlled trials, meta-analyses, and a Cochrane systematic review across indications including Alzheimer's disease, vascular dementia, and stroke
10.3389/fpls.2017.01457 107 MartinoiaE.GrillE.TommasiniR.KreuzK.AmrheinN
Potential Benefits Tissue repair (preclinical): GHK-Cu, BPC-157 and TB-500 are individually reported to support wound healing, collagen and angiogenesis in animal and cell models [5] [6]
Additionally, elevated levels of the plasma amino acid homocysteine can be a functional marker of folate, vitamin B12, or vitamin B6 deficiency, as all these vitamins are required to convert homocysteine into methionine